Sun Pharmaceutical Industries Ltd on Wednesday reported a 34 per cent jump in its consolidated net profit at Rs 2,654.5 crore for the January-March quarter of 2023-24, compared to the same period of the previous year. The pharma major's consolidated revenue for the quarter stood at Rs 11,982.9 crore, up 9 per cent from Rs 1,0930.6 crore in the same period last year.